Company sniffs unique opportunity with nasal COVID-19 vaccine

With a new CEO at the helm and a radical pivot in product strategy, Tampa-based Oragenics has taken risks that, if successful, could make it the next big name in pharmaceuticals.

Kim Murphy was named CEO of Oragenics in June. (Photo by Mark Wemple)
Kim Murphy was named CEO of Oragenics in June. (Photo by Mark Wemple)
  • Health Care
  • Share

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • March 21, 2026
Clearwater office building sells to local firm for $5.3M
  • March 21, 2026
One year in, growing St. Pete insurer posts $2M profit
  • March 20, 2026
$10.25M Naples bayfront penthouse heads to auction
  • March 20, 2026
Bentley dealership opens in downtown Sarasota

Sponsored Content